A carregar...
Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancer
BACKGROUND: Tasquinimod is a quinoline-3-carboxamide derivative with anti-angiogenic activity. Two open-label phase I clinical trials in patients were conducted to evaluate the safety and tolerability of tasquinimod, with additional pharmacokinetic and efficacy assessments. METHODS: Patients with ca...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2768463/ https://ncbi.nlm.nih.gov/pubmed/19755981 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605322 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|